Preparation methods for a novel generation of biological safe KLH products used for cancer treatment, for the development of conjugated therapeutic vaccines and as challenging agents

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 10800820
APP PUB NO 20170121376A1
SERIAL NO

15318286

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to the provision of a biologically safe hemolymph sera, preferably hemocyanin, more preferably KLH (keyhole limpet hemocyanin). The hemocyanin is purified using anion exchange chromatography.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
BIOSYN ARZNEIMITTEL GMBHSCHORNDORFER STRASSE 32 FELLBACH 70734

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Kottwitz, Ortwin Korntal-Münchingen, DE 4 0
Muddukrishna, Shammana N Carlsbad, US 2 0
Stiefel, Thomas Stuttgart, DE 17 16

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
7.5 Year Payment $3600.00 $1800.00 $900.00 Apr 13, 2028
11.5 Year Payment $7400.00 $3700.00 $1850.00 Apr 13, 2032
Fee Large entity fee small entity fee micro entity fee
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00